Salvatore Funiciello PhD
Medical Director at Zogenix, Inc.- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Experience
-
Zogenix, Inc.
-
United States
-
Pharmaceutical Manufacturing
-
1 - 100 Employee
-
Medical Director
-
Sep 2019 - Present
Roma, Italia
-
-
-
HRA Pharma
-
France
-
Pharmaceutical Manufacturing
-
100 - 200 Employee
-
Country Lead Italy at HRA Pharma Rare Diseases
-
Jun 2019 - Sep 2019
Roma, Italia
-
-
-
Syneos Health Commercial Solutions
-
United States
-
Biotechnology Research
-
500 - 600 Employee
-
Medical Science Liaison
-
Oct 2018 - May 2019
Milano, Italia
-
-
-
Alexion Pharmaceuticals, Inc.
-
United States
-
Biotechnology Research
-
700 & Above Employee
-
Medical Science Liaison
-
Sep 2015 - Sep 2018
-
-
-
Synageva BioPharma Corp.
-
United States
-
Biotechnology Research
-
1 - 100 Employee
-
Senior Associate Medical Director and MSL
-
Jan 2015 - Aug 2015
-
-
Associate Medical Director and Medical Science Liaison Italy
-
Apr 2014 - Dec 2014
Working on Lysosomal Acid Lipase Deficit and Lysosomal Storage Disorders (LSD). Organization, management and follow up of IIR (Investigator-initiated Research), of CSS (Company Sponsor Studies), of National and Regional Advisory Boards. Organization of Hospital meetings, participation to International, National and local Congress, Management of KOL's involved in rare diseases (Adu/Ped Gastro-hepatologists, Metabolic disorders specialists, laboratorists etc.
-
-
-
Orphan Europe
-
Pharmaceutical Manufacturing
-
1 - 100 Employee
-
Orphan Drug Specialist and Medical Product Specialist
-
Jan 2012 - Mar 2014
Medical Management of Pedea (I.V. Ibuprofen) for the treatment of Patent Ductus Arteriosus (PDA) in premature babies with less than 34 weeks of gestational age.
-
-
Orphan Drug Specialist
-
May 2003 - Mar 2014
Responsible for the Management of the business in centre south of Italy. Main actvity is dedicaded to all the KOL's from the Regional Health Authorities to Head of Medical and Pharmacy Departments and all the people involved in rare deseases and orphan drugs.
-
-
ODS Coordinator
-
Jan 2007 - Oct 2009
Ad interim responsible for the coordination of ODS's in Italy and as well as for the management of the business in the centre south of Italy.
-
-
-
Chiesi Group
-
Italy
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Medical Sales Specialist
-
Jan 2001 - May 2003
Managing the business in Rome Area promoting company drugs portfolio.
-
-
-
-
Medical Sales Representative
-
Sep 1999 - Dec 2000
Sales and promotion of company drugs portfolio to different target physicians, from GP's to cardiologists, gynecologists, internists, orthopaedics, otorhinolaryngologists and pneumologists, pediatricians.
-
-
-
-
Biologist Director
-
Jun 1998 - Oct 1998
Managing the execution and the validation of analytical biochemical exams both from the internal hospital departments and from external requesting centers.
-
-
Education
-
Sapienza Università di Roma
Post Graduate/PhD/Specialization, Clinical Pathology and Biochemistry -
Sapienza Università di Roma
National Examination, Clinical Biochemistry, Clinical Pathology -
Sapienza Università di Roma
BD Biological Sciences Degree, Biology and Molecular Biology -
Orphan Europe Education Programme
Orphan Drug Specialist Education Programme, Development of drugs for rare disease and their access to the market